0001144204-11-040430.txt : 20110713
0001144204-11-040430.hdr.sgml : 20110713
20110713193155
ACCESSION NUMBER: 0001144204-11-040430
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110622
FILED AS OF DATE: 20110713
DATE AS OF CHANGE: 20110713
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: KERYX BIOPHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001114220
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 134087132
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 750 LEXINGTON AVENUE
STREET 2: .
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: 212-531-5965
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fowler Wyche JR
CENTRAL INDEX KEY: 0001381064
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30929
FILM NUMBER: 11966679
MAIL ADDRESS:
STREET 1: KERYX BIOPHARMACEUTICALS, INC.
STREET 2: 750 LEXINGTON AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10022
4
1
v228526_ex.xml
X0303
4
2011-06-22
0
0001114220
KERYX BIOPHARMACEUTICALS INC
KERX
0001381064
Fowler Wyche JR
KERYX BIOPHARMACEUTICALS, INC.
750 LEXINGTON AVENUE
NEW YORK
NY
10022
1
0
0
0
Common Stock
2011-06-22
4
A
0
15000
0
A
120000
D
Stock Options (Right to Buy)
4.38
2011-06-22
4
A
0
25000
0
A
2012-06-22
2021-06-22
Common Stock
25000
25000
D
One third of the shares of restricted stock vest on 06/22/2012; one third vest on 06/22/2013; and one third vest on
06/22/2014.
Of the 120,000 shares, 25,000 shares are restricted common stock.
One third of the stock options vest on 06/22/2012; one third vest on 06/22/2013; and one third vest on 06/22/2014.
/s/ James F. Oliviero, Attorney-in-Fact
2011-07-13